Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is N/A as of 2026-10-06T16:36:53.971Z.
Calculation as of: 2026-10-06T16:36:53.971Z.
Quote observation: 2026-10-06T16:34:50.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
N/A
Market Cap
$3.35M
PB Ratio
0.82
TTM Avg
4.65
3Y Avg
3.56
5Y Avg
3.55
Market Cap
$3.24M
PB Ratio
0.10
TTM Avg
320.85
3Y Avg
911.35
5Y Avg
666.87
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eocene Ltd. (EOCN) | $3.46M | N/A | N/A | N/A | N/A |
| Evogene Ltd. (EVGN)vs › | $3.46M | N/A | 7.82 | 4.46 | 9.07 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.46 | 0.83 | 232.76 | 141.77 |
| Moolec Science S.A. (MLEC)vs › | $3.47M | N/A | 28.34 | 61.29 | 193.70 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.35M | 0.82 | 4.65 | 3.56 | 3.55 |
| Nexalin Technology, Inc. (NXL)vs › | $3.51M | 2.31 | 2.72 | 3.76 | 3.14 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | 0.63 | 1.12 | 2.59 | 3.22 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.24M | 0.10 | 320.85 | 911.35 | 666.87 |
| IceCure Medical Ltd (ICCM)vs › | $3.13M | 0.26 | 4.39 | 5.59 | 5.08 |
| MBody AI Ltd. (MBAI)vs › | $3.18M | 0.93 | N/A | N/A | N/A |
P/B Ratio
N/A
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
